StonvexLoading…
StonvexStonvexStonvexCore line items from RMNI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $421.54M | $428.75M | $431.50M | $409.66M |
Operating Income | $59.91M | $-32.13M | $43.77M | $8.09M |
Net Income | $37.10M | $-36.27M | $26.06M | $-2.48M |
EPS (Diluted) | $0.39 | $-0.40 | $0.29 | $-0.03 |
Total Assets | $423.11M | $369.06M | $393.80M | $391.04M |
Total Liabilities | $450.14M | $438.51M | $433.29M | $468.21M |
Cash & Equivalents | $119.97M | $88.79M | $115.42M | $109.01M |
Free Cash Flow OCF − CapEx | $55.65M | $-42.23M | $5.25M | $30.57M |
Shares Outstanding | 91.60M | 91.12M | 89.59M | 88.52M |